Masimo Announces Development Of Delta CHb, HHb, And O2Hb Indices For...
- ICU
- 09/09/2019
Masimo Announces Development Of Delta CHb, HHb, And O2Hb Indices For O3®
READ MOREMasimo Announces Development Of Delta CHb, HHb, And O2Hb Indices For O3®
READ MOREMasimo Announces Pathway™ For The Root® Patient Monitoring And Connectivity Platform
READ MOREMerger: Novalung Becomes Fully Integrated within Xenios
READ MOREStudy: The Utility Of Masimo ORi™ To Reduce Hyperoxia In Critically Ill Patients
READ MOREFinalists of the 2019 IHF Awards Unveiled
READ MORESpot on for Healthcare Technology Startups at XPOMET© Medicinale©
READ MOREEnhanced Hemodynamic Assessment in Physiological Research
READ MOREAbu Dhabi to host the 2nd International Patient Experience Symposium in November
READ MOREAffidea Continues its Expansion Plans with a New Acquisition in Italy
READ MORELargest Blockchain Project Signed Between BP Batam, Indonesia and dClinic
READ MORE